Taglutimide

Taglutimide (Biglumide; K 2004) is an orally active hypnotic agent. Taglutimide lowers plasma levels of diphenhydramine in rats and shortens the duration of anesthesia. Taglutimide is used in research on neurological disorders such as sedation and hypnosis[1][2].

Product Specifications

CAS Number

[14166-26-8]

Product Name Alternative

Biglumide; K 2004

UNSPSC

12352005

Target

Others

Related Pathways

Others

Field of Research

Neurological Disease

Smiles

O=C1NC(C(CC1)N2C(C3C(C4CCC3C4)C2=O)=O)=O

Molecular Formula

C14H16N2O4

Molecular Weight

276.29

References & Citations

[1]Jurecka W, et al. Teratologisch-neurotoxische Prüfung von Biglumid (K-2004) und Thalidomid [Teratologic-neurotoxicologic studies on biglumide (K-2004) and thalidomide]. Arch Toxicol. 1977 Jun 18;37 (2) :165-72. German. |[2]Wiener H, et al. Induction of drug metabolism in the rat by taglutimide, a sedative-hypnotic glutarimide derivative. Eur J Drug Metab Pharmacokinet. 1980;5 (2) :93-7.